Back to Market Feed

REPATHA 140 MG/ML SYRINGE

Evolocumab
$281.2450per ML

Strength

140 mg/mL

Manufacturer

Amgen Inc.

NDC

72511075001

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/7/2026

Active Ingredients

EVOLOCUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125522

On Market Since

10/9/2018

Pharmacological Classes

Antibodies
Monoclonal
PCSK9 Inhibitor
PCSK9 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+1.9%

1Y

+1.8%

3Y

+5.7%

5Y

+22.3%

All

+28.8%

Generic Alternatives

1 alternative • Same active ingredient

REPATHA 140 MG/ML SYRINGE
Brand
72511050101•Amgen Inc.
$281.2448

Related Drugs

Same classification

PRALUENT 75 MG/ML PEN
Brand
61755002002•Regeneron Pharmaceuticals, Inc.
$258.0650
per ML
PRALUENT 150 MG/ML PEN
Brand
61755002102•Regeneron Pharmaceuticals, Inc.
$258.1639
per ML
DUPIXENT 300 MG/2 ML PEN
Brand
00024591502•Sanofi-Aventis U.S. LLC
$1008.4070
per ML
DUPIXENT 300 MG/2 ML SYRINGE
Brand
00024591401•Sanofi-Aventis U.S. LLC
$1009.9578
per ML
DUPIXENT 200 MG/1.14 ML PEN
Brand
00024591902•Sanofi-Aventis U.S. LLC
$1772.9914
per ML
DUPIXENT 200 MG/1.14 ML SYRING
Brand
00024591801•Sanofi-Aventis U.S. LLC
$1774.7544
per ML